The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Mammalian Cell Fermentation Technology Global Market Report 2024, the mammalian cell fermentation technology market is expected to show significant growth in the forecast period.

The mammalian cell fermentation technology market has experienced significant growth in recent years and is poised for continued expansion. This blog delves into the key trends, drivers, and future outlook for the industry.

Current Market Overview

• Market Size and Growth:
  • 2023: $46.05 billion
  • 2024: $51.29 billion (11.4% CAGR)
  • 2028: $80.16 billion (11.8% CAGR)
• Growth Drivers: Increased demand for biologics and biosimilars, focus on personalized medicine, scalable cell culture methods.

Key Market Drivers

• Demand for Biologics:
  • High Growth: Biologics are essential for treating diseases such as cancer and autoimmune disorders.
  • Regulatory Support: Increased FDA approvals (55 new drugs in 2023) boost market demand.
  • Technological Efficiency: Mammalian cell fermentation supports complex biologics production.
• Advancements in Technology:
  • Innovations: Cloud bioreactors by Culture Bioscience enhance scalability and flexibility.
  • Integration of Multi-Omics: Advances in bioreactor design and bioprocessing techniques.

View More On The Mammalian Cell Fermentation Technology Market Report 2024 – https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Market Segmentation

• By Type:
  • Chinese Hamster Ovary Cell Fermentation
  • Human Embryonic Kidney Cell Fermentation
  • Baby Hamster Kidney Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Other Types
• By Application:
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Other Applications
• By End-Use:
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs)
  • Academic and Research Institutes

Major Companies in the Market

• Key Players:
  • AbbVie Inc.
  • Thermo Fisher Scientific Inc.
  • AstraZeneca PLC
  • Roche Holdings Inc.
  • Merck KGaA
  • Lonza Group Ltd.
  • Boehringer Ingelheim GmbH
  • Catalent Inc.
  • Sartorius AG
  • Nordmark Pharma GmbH
  • Scorpius BioManufacturing Inc.

Future Trends and Predictions

• Market Growth:
  • Driven by increasing prevalence of chronic diseases.
  • Rising investments from multinational corporations.
  • Expansion in advanced bioprocessing and novel recombinant proteins research.
• Technological Trends:
  • Development of next-generation bioprocessing technologies.
  • Enhanced automation and integration of multi-omics approaches.
• Regional Insights:
  • North America: Largest market in 2023.
  • Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

Strategic Moves and Acquisitions

• Chrysea Limited’s Acquisition:
  • Acquired Rodon Biologics to enhance capabilities in synthetic biology and biopharmaceuticals.
  • Focus on integrating expertise in protein engineering and production.

Conclusion
The mammalian cell fermentation technology market is on an impressive growth trajectory, fueled by the rising demand for biologics and advancements in biotechnological innovations. With key players investing in cutting-edge technologies and strategic acquisitions, the market is set to expand further, presenting numerous opportunities for stakeholders in the coming years.

Request A Sample Of The Global Mammalian Cell Fermentation Technology Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16473&type=smp